Document is current
Any future updates will be listed below
-
Authors
Hawkins, Jaclynn https://orcid.org/0000-0001-8132-790X
Kloss, Katherine
Funnell, Martha
Nwankwo, Robin
Schwenzer, Claudia
Smith, Fonda
Piatt, Gretchen
-
Funding
Funding for this research was provided by:
Blue Cross Blue Shield of Michigan Foundation (3063.MG)
Claude D. Pepper Older Americans Independence Center, University of Michigan (2P30AG024824-16)
- License Information
-
More Information
Article History
Received: 5 March 2021
Accepted: 11 March 2021
First Online: 22 March 2021
Declarations
:
: This study protocol outlined in Table has been reviewed and approved by the University of Michigan Health Sciences Center Institutional Review Board (HUM00190932). All individuals interested in participation will be required to provide a written informed consent document approved by the University of Michigan Institutional Review Board (UM IRB). At the baseline screening assessment session, eligible participants will complete the Informed Consent form. Consent forms will include all required elements of informed consent, including purpose of the study, duration, voluntary participation, alternatives and right to withdraw. Participants will be told that they will be compensated for each study assessment and that the intervention will be provided to them at no cost. In addition, the consent form will discuss the fact that participants have an equal chance of being randomized to either treatment condition. Participants will be provided with a copy of the informed consent form for their records.
: Not applicable.
: The authors declare that they have no competing interests.
